Provided by Tiger Fintech (Singapore) Pte. Ltd.

Surmodics

32.05
-0.3900-1.20%
Post-market: 32.050.00000.00%17:43 EDT
Volume:148.42K
Turnover:4.75M
Market Cap:458.29M
PE:-22.92
High:32.32
Open:32.32
Low:31.81
Close:32.44
Loading ...

SurModics Reports Cyberattack, Says Critical IT Systems Restored

MT Newswires Live
·
03 Jul

BRIEF-Surmodics Reports Unauthorized Access To It Systems

Reuters
·
02 Jul

Surmodics Inc - Initiates Containment Measures After Cyber Incident - SEC Filing

THOMSON REUTERS
·
02 Jul

Surmodics Inc - Reports Unauthorized Access to It Systems - SEC Filing

THOMSON REUTERS
·
02 Jul

Are Options Traders Betting on a Big Move in Surmodics Stock?

Zacks
·
02 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Icon (ICLR), Reviva Pharmaceuticals Holdings (RVPH) and SurModics (SRDX)

TIPRANKS
·
01 May

Surmodics Reports Q2 2025 Results Amid Acquisition Challenges

TIPRANKS
·
01 May

SurModics Down Over 8%, On Track for Largest Percent Decrease Since March 2023 -- Data Talk

Dow Jones
·
30 Apr

SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks
·
30 Apr

SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates

Zacks
·
30 Apr

Surmodics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
30 Apr

Surmodics reports Q2 EPS (13c), consensus (11c)

TIPRANKS
·
30 Apr

BRIEF-Surmodics Expects FY25 Financial Performance To Remain Impacted By Lower Surveil DCB License Fee, Product Revenue

Reuters
·
30 Apr

Surmodics Tariff Exposure Related to Supply Chain Represents Modest Percentage of Total Product Sales

THOMSON REUTERS
·
30 Apr

Surmodics Expects FY25 Financial Guidance Does Not Reflect Possible Tariff Impacts

THOMSON REUTERS
·
30 Apr

Surmodics Tariff Exposure From Customer Medical Device and Test Kit Sales Is Difficult to Quantify

THOMSON REUTERS
·
30 Apr

Surmodics Expects FY25 Financial Performance to Remain Impacted by Lower Surveil Dcb License Fee, Product Revenue

THOMSON REUTERS
·
30 Apr

SurModics: Fiscal Q2 Earnings Snapshot

Associated Press Finance
·
30 Apr

Surmodics Q2 Adj. EPS $(0.13) Misses $(0.11) Estimate, Sales $28.09M Miss $32.23M Estimate

Benzinga
·
30 Apr

BRIEF-Surmodics Q2 EPS USD -0.36

Reuters
·
30 Apr